Also irritates the stomach and can worsen GI side effects like nausea or reflux
Retatrutide is currently an investigational drug in Phase 3 clinical trials (the TRIUMPH program) conducted by Eli Lilly
Visceral fat accumulation in particular is both a symptom and a driver of worsening insulin resistance
Their model emphasizes quick recovery, localized anesthesia (patient awake), and tailored treatment rather than one-size-fits-all
Altintas Dogan et al 75 experiment found that liraglutide significantly reduced body weight, decreased inflammatory markers such as IL-6 and MCP-1, increased exertional spirometry (FVC) and carbon monoxide diffusion capacity, and improved COPD assessment test scores, but no significant improvement in FEV1, FEV1/FVC, or 6-minute walk tests, suggesting the possibility that GLP-1RA may reduce inflammatory responses, improve lung function, and mitigate the degree of impaired health in patients with COPD
doi: 10.1002/oby.24037